Literature DB >> 19041669

Analysis of an Actinobacillus pleuropneumoniae multi-resistance plasmid, pHB0503.

Mingsong Kang1, Rui Zhou, Lei Liu, Paul R Langford, Huanchun Chen.   

Abstract

A plasmid containing multidrug resistance genes has been discovered from a clinical Actinobacillus pleuropneumoniae strain isolated in China. The complete 15079kb sequence of this plasmid, designated pHB0503, was analyzed with regard to the organization and evolution of multidrug resistance genes. The deduced amino acid sequences from seven open reading frames (sul2 catA3, aacC2, strA, truncated strB (strB'), bla(ROB-1) and aph(3')-I) identified in pHB0503 were entirely or nearly identical to resistance genes of plasmids both within and outside of the family Pasteurellaceaea, indicating that pHB0503 arose through inter-plasmid recombination processes among them. In addition, co-transcription of the cluster of resistance genes from the promoter upstream of sul2 and bla(ROB-1) was confirmed by RT-PCR. This is the first report of a complete sequence of the plasmid containing seven resistance genes from A. pleuropneumoniae.

Entities:  

Mesh:

Year:  2008        PMID: 19041669     DOI: 10.1016/j.plasmid.2008.11.001

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  9 in total

1.  The mosaicism of plasmids revealed by atypical genes detection and analysis.

Authors:  Emanuele Bosi; Renato Fani; Marco Fondi
Journal:  BMC Genomics       Date:  2011-08-08       Impact factor: 3.969

2.  Screening of Actinobacillus pleuropneumoniae LuxS inhibitors.

Authors:  Lu Li; Lili Sun; Yunfeng Song; Xinjuan Wu; Xuan Zhou; Ziduo Liu; Rui Zhou
Journal:  Curr Microbiol       Date:  2013-06-07       Impact factor: 2.188

3.  Monoclonal antibodies against Actinobacillus pleuropneumoniae TonB2 protein expressed in Escherichia coli.

Authors:  Jinlin Liu; Jihong Yang; Bin Li; Yanli Liu; Yuting Tu; Jin Zhao; Weicheng Bei; Chao Qi
Journal:  Hybridoma (Larchmt)       Date:  2012-10

4.  Construction of new cloning, lacZ reporter and scarless-markerless suicide vectors for genetic studies in Aggregatibacter actinomycetemcomitans.

Authors:  María Dolores Juárez-Rodríguez; Ascención Torres-Escobar; Donald R Demuth
Journal:  Plasmid       Date:  2013-01-23       Impact factor: 3.466

5.  Identification of drug target candidates of the swine pathogen Actinobacillus pleuropneumoniae by construction of protein-protein interaction network.

Authors:  Siqi Li; Zhipeng Su; Chengjun Zhang; Zhuofei Xu; Xiaoping Chang; Jiawen Zhu; Ran Xiao; Lu Li; Rui Zhou
Journal:  Genes Genomics       Date:  2018-05-03       Impact factor: 1.839

6.  Comparison of Haemophilus parasuis reference strains and field isolates by using random amplified polymorphic DNA and protein profiles.

Authors:  Emilie S Zehr; Dennis V Lavrov; Louisa B Tabatabai
Journal:  BMC Microbiol       Date:  2012-06-15       Impact factor: 3.605

7.  Identification of dfrA14 in two distinct plasmids conferring trimethoprim resistance in Actinobacillus pleuropneumoniae.

Authors:  Janine T Bossé; Yanwen Li; Stephanie Walker; Tom Atherton; Roberto Fernandez Crespo; Susanna M Williamson; Jon Rogers; Roy R Chaudhuri; Lucy A Weinert; Olusegun Oshota; Matt T G Holden; Duncan J Maskell; Alexander W Tucker; Brendan W Wren; Andrew N Rycroft; Paul R Langford
Journal:  J Antimicrob Chemother       Date:  2015-05-08       Impact factor: 5.790

8.  Whole Genome Sequencing for Surveillance of Antimicrobial Resistance in Actinobacillus pleuropneumoniae.

Authors:  Janine T Bossé; Yanwen Li; Jon Rogers; Roberto Fernandez Crespo; Yinghui Li; Roy R Chaudhuri; Matthew T G Holden; Duncan J Maskell; Alexander W Tucker; Brendan W Wren; Andrew N Rycroft; Paul R Langford
Journal:  Front Microbiol       Date:  2017-03-06       Impact factor: 5.640

9.  Whole-genome sequence analyses of Glaesserella parasuis isolates reveals extensive genomic variation and diverse antibiotic resistance determinants.

Authors:  Xiulin Wan; Xinhui Li; Todd Osmundson; Chunling Li; He Yan
Journal:  PeerJ       Date:  2020-06-22       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.